首页> 外文期刊>Case Reports in Hematology >A Unique “Composite” PTLD with Diffuse Large B-Cell and T/Anaplastic Large Cell Lymphoma Components Occurring 17 Years after Transplant
【24h】

A Unique “Composite” PTLD with Diffuse Large B-Cell and T/Anaplastic Large Cell Lymphoma Components Occurring 17 Years after Transplant

机译:独特的“复合” PTLD,其在移植后17年出现弥漫性大B细胞和T /间变性大细胞淋巴瘤成分

获取原文
           

摘要

Posttransplant lymphoproliferative disorder (PTLD) comprises a spectrum ranging from polyclonal hyperplasia to aggressive monoclonal lymphomas. The majority of PTLDs are of B-cell origin while T-cell PTLDs and Hodgkin lymphoma-like PTLDs are uncommon. Here, we report a unique case of a 56-year-old man in whom a lymphoma with two distinct components developed as a duodenal mass seventeen years following a combined kidney-pancreas transplant. This PTLD, which has features not previously reported in the literature, consisted of one component of CD20 positive and EBV negative monomorphic diffuse large B-cell lymphoma. The other component showed anaplastic morphology, expressed some but not all T-cell markers, failed to express most B-cell markers except for PAX5, and was diffusely EBV positive. Possible etiologies for this peculiar constellation of findings are discussed and the literature reviewed for “composite-like” lymphomas late in the posttransplant setting.
机译:移植后淋巴增生性疾病(PTLD)的频谱范围从多克隆增生到侵袭性单克隆淋巴瘤。大多数PTLD起源于B细胞,而T细胞PTLD和类似霍奇金淋巴瘤的PTLD并不常见。在这里,我们报道了一个56岁的男性的独特病例,其中在肾脏和胰腺联合移植后17年,具有两个不同成分的淋巴瘤发展为十二指肠肿块。该PTLD具有以前文献中未报道的特征,由CD20阳性和EBV阴性单态性弥漫性大B细胞淋巴瘤的一种成分组成。其他成分显示间变性形态,表达一些但不是全部T细胞标记,除PAX5以外不能表达大多数B细胞标记,并且EBV呈弥漫性阳性。讨论了这种特殊的发现可能的病因,并在移植后后期对“复合样”淋巴瘤进行了文献综述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号